SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Blackstone to Provide Johnson & Johnson $750 Million for OLN324 Phase 3 Program

Funds managed by Blackstone Life Sciences agreed to provide $750 million in development funding for the program.

JNJBX

Related stories